Updated Jul 16, 2026
Yeganeh Reuven is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $33.32M.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-18 | PHGE | BiomX Inc. | S — Open-market sale | 530.0K | $5.00 | $2.65M |
| 2026-03-18 | PHGE | BiomX Inc. | J — Other acquisition / disposition | 530.0K | $2.00 | $1.06M |
| 2026-03-18 | PHGE | BiomX Inc. | S — Open-market sale | 450.0K | $5.00 | $2.25M |
| 2026-03-18 | PHGE | BiomX Inc. | J — Other acquisition / disposition | 450.0K | $2.00 | $900K |
| 2026-03-13 | PHGE | BiomX Inc. | S — Open-market sale | 370.0K | $5.00 | $1.85M |
| 2026-03-13 | PHGE | BiomX Inc. | J — Other acquisition / disposition | 370.0K | $2.00 | $740K |
| 2026-03-13 | PHGE | BiomX Inc. | S — Open-market sale | 300.0K | $5.00 | $1.50M |
| 2026-03-13 | PHGE | BiomX Inc. | J — Other acquisition / disposition | 300.0K | $2.00 | $600K |
| 2025-11-20 | DFNS | Nukkleus Inc. | A — Grant or award | 10.0K | $0.00 | |
| 2024-12-20 | DFNS | Nukkleus Inc. | A — Grant or award | 10.0K | $1.39 | $14K |
Yeganeh Reuven is a corporate insider — currently tracked as Director, 10% Owner. InsiderAlpha tracks every SEC Form 4 filing in real time.
Recorded transactions: 0 open-market purchases () and 7 open-market sales ($33.32M) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Yeganeh Reuven profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.